Ambros Therapeutics, Inc. today announced that the first patient has been dosed in its pivotal CRPS-RISE Phase 3 clinical trial evaluating neridronate versus placebo for the treatment of Complex ...
This week we are going to write about a condition that is somewhat rare but does occur and when it does occur it is extremely problematic for the patient. The condition? Complex regional pain syndrome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results